Medicare Enrolled
Dr. Hemang Dave, M.D.
Hematology & Oncology · Marmora, NJ
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Dave from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Dave?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Dave
Dr. Hemang Dave is a hematology & oncology specialist in Marmora, NJ, with 20 years of NPI registration. Based on federal Medicare data, Dr. Dave performed 63,227 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Dave received a total of $21,117 from 102 pharmaceutical and/or device companies across 833 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Dave is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 19% volume in NJ
$21,117 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗63,227
Medicare services
Top 19% in NJ for hematology & oncology
Not available
Unique patients (not deduplicated)
$14
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Filgrastim injection, 1 microgram An injection of filgrastim, a medication that stimulates the production of white blood cells. This code specifically covers the brand-name drug and excludes biosimilar versions. |
16,860 | $1 | $3 |
| Epoetin alfa injection (Retacrit) for anemia An injection of a biosimilar form of epoetin alfa used for non-end-stage renal disease purposes. The dose administered is 1000 units. |
7,500 | $6 | $26 |
| Pembrolizumab injection (Keytruda) | 6,800 | $43 | $117 |
| Epoetin alfa injection (Procrit) for anemia An injection of epoetin alfa containing 1000 units for use in patients not on end-stage renal disease (ESRD) dialysis. |
6,680 | $6 | $53 |
| Denosumab injection (Prolia/Xgeva) | 6,120 | $18 | $61 |
| Iron sucrose injection (Venofer) An injection of iron sucrose used to replenish iron levels in the body. |
4,800 | $0 | $2 |
| Iron infusion (Monoferric) | 4,100 | $16 | $70 |
| Immune globulin infusion (Gammagard) An injection of immune globulin (Gammagard Liquid) to provide antibodies. The dose specified is 500 mg. |
1,820 | $36 | $176 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
1,312 | $8 | $32 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
1,291 | $0 | $1 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
1,242 | $8 | $18 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
501 | $12 | $82 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
494 | $99 | $231 |
| Injection, granisetron hydrochloride, 100 mcg | 490 | $0 | $22 |
| Pegfilgrastim-cbqv injection An injection of pegfilgrastim-cbqv, a biosimilar medication, administered at a dose of 0.5 mg. |
469 | $107 | $825 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
320 | $25 | $126 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
205 | $146 | $308 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
188 | $111 | $548 |
| Unclassified drug A medication that does not fit into standard HCPCS or CPT classification categories. |
186 | $1 | $13 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
180 | $66 | $158 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
156 | $67 | $152 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
153 | $1 | $5 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
150 | $54 | $261 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
149 | $17 | $81 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
115 | $24 | $121 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
110 | $60 | $196 |
| Hospital follow-up visit, low complexity Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service. |
110 | $41 | $109 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
102 | $1 | $15 |
| Prothrombin time test (blood clotting) A laboratory test that measures how long it takes for blood to clot. This procedure evaluates the body's coagulation process. |
90 | $4 | $25 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
87 | $142 | $424 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
68 | $13 | $98 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
64 | $18 | $62 |
| Venipuncture for blood collection A procedure to draw blood from a vein for medical testing or analysis. |
62 | $78 | $248 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
47 | $99 | $232 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
44 | $57 | $253 |
| Anticoagulant management for warfarin Management of anticoagulant therapy for a patient taking warfarin. This service involves monitoring and adjusting the medication regimen. |
41 | $9 | $33 |
| New patient office visit, complex (60-74 min) | 36 | $176 | $444 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
34 | $108 | $297 |
| Prolonged office E/M service, first 15 minutes This code is used for additional time spent by a physician beyond the maximum required time of a primary office or outpatient evaluation and management service. It is billed in 15-minute increments based on total time spent on the date of the primary service. |
26 | $27 | $65 |
| Irrigation of implanted venous access device This procedure involves flushing an implanted venous access device to clear blockages or maintain patency. It ensures the device remains functional for delivering medications or fluids. |
25 | $22 | $91 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
10.7% high complexity
82.3% medium
7.0% routine
Industry Payment Transparency
Open Payments through 2024 ↗$21,117
Total received (2018-2024)
Avg $3,017/year across 7 years
Top 12% in NJ for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
102
Companies
833
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,507
2023
$1,948
2022
$5,898
2021
$3,101
2020
$3,604
2019
$2,047
2018
$2,012
Payments by company (2024)
PFIZER INC.
$302
Janssen Biotech, Inc.
$222
Novartis Pharmaceuticals Corporation
$158
Astellas Pharma US Inc
$147
Seapearl East, Inc
$126
EMD Serono, Inc.
$109
Celgene Corporation
$101
AstraZeneca Pharmaceuticals LP
$93
Merck Sharp & Dohme LLC
$89
Gilead Sciences, Inc.
$86
E.R. Squibb & Sons, L.L.C.
$85
Daiichi Sankyo Inc.
$74
Eisai Inc.
$71
Acrotech Biopharma Inc.
$63
Bayer Healthcare Pharmaceuticals Inc.
$58
GlaxoSmithKline, LLC.
$53
Spectrum Pharmaceuticals Inc.
$45
Kite Pharma, Inc.
$44
Genmab U.S., Inc.
$41
ADC Therapeutics America, Inc.
$41
GENZYME CORPORATION
$40
Alexion Pharmaceuticals, Inc.
$38
Aveo Pharmaceuticals, Inc.
$38
ARRAY BIOPHARMA INC
$36
Incyte Corporation
$33
JAZZ PHARMACEUTICALS INC.
$32
SpringWorks Therapeutics, Inc.
$32
Rigel Pharmaceuticals, Inc.
$30
Fresenius Kabi USA, LLC
$23
Takeda Pharmaceuticals U.S.A., Inc.
$23
Lilly USA, LLC
$22
Deciphera Pharmaceuticals Inc.
$20
Mirati Therapeutics, Inc.
$20
BeiGene USA, Inc.
$18
TerSera Therapeutics LLC
$18
PUMA BIOTECHNOLOGY, INC.
$17
TAIHO ONCOLOGY, INC.
$16
Genentech USA, Inc.
$16
Exelixis Inc.
$14
ABBVIE INC.
$14
Top 3 companies account for 27.2% of 2024 payments
All-time payments by company (2018-2024) ›
Kite Pharma, Inc.
$4,330
AstraZeneca Pharmaceuticals LP
$2,404
Blueprint Medicines Corporation
$1,494
Novartis Pharmaceuticals Corporation
$1,403
E.R. Squibb & Sons, L.L.C.
$954
PFIZER INC.
$873
Janssen Biotech, Inc.
$717
Genentech USA, Inc.
$586
Incyte Corporation
$496
Amgen Inc.
$466
Seagen Inc.
$453
Merck Sharp & Dohme Corporation
$435
Astellas Pharma US Inc
$391
Celgene Corporation
$355
Merck Sharp & Dohme LLC
$350
Eisai Inc.
$346
Bayer HealthCare Pharmaceuticals Inc.
$334
Lilly USA, LLC
$283
Gilead Sciences, Inc.
$256
GlaxoSmithKline, LLC.
$228
Daiichi Sankyo Inc.
$206
Takeda Pharmaceuticals U.S.A., Inc.
$184
GENZYME CORPORATION
$181
EISAI INC.
$143
Pharmacyclics LLC, An AbbVie Company
$134
Seapearl East, Inc
$126
Bayer Healthcare Pharmaceuticals Inc.
$124
Pharmacosmos Therapeutics Inc.
$122
Taiho Oncology, Inc.
$122
EMD Serono, Inc.
$109
Karyopharm Therapeutics Inc.
$108
Exelixis Inc.
$107
Puma Biotechnology, Inc.
$102
Rigel Pharmaceuticals, Inc.
$95
ARRAY BIOPHARMA INC
$87
TESARO, Inc.
$86
Genmab U.S., Inc.
$74
Seattle Genetics, Inc.
$73
Boehringer Ingelheim Pharmaceuticals, Inc.
$68
Acrotech Biopharma Inc.
$63
Spectrum Pharmaceuticals Inc.
$60
SERVIER PHARMACEUTICALS LLC
$56
Heron Therapeutics, Inc.
$54
Alexion Pharmaceuticals, Inc.
$53
NanoString Technologies, Inc.
$51
JAZZ PHARMACEUTICALS INC.
$46
Deciphera Pharmaceuticals Inc.
$44
Servier Pharmaceuticals LLC
$42
Sysmex Inostics Inc
$42
Mirati Therapeutics, Inc.
$41
ADC Therapeutics America, Inc.
$41
Aurobindo Pharma USA, Inc.
$41
Foundation Medicine, Inc.
$39
Aveo Pharmaceuticals, Inc.
$38
Verastem, Inc.
$38
Adaptive Biotechnologies Corporation
$35
Janssen Pharmaceuticals, Inc
$34
Agios Pharmaceuticals, Inc.
$34
BeiGene USA, Inc.
$34
Regeneron Healthcare Solutions, Inc.
$33
SpringWorks Therapeutics, Inc.
$32
AbbVie, Inc.
$31
Global Blood Therapeutics, Inc.
$29
Kyowa Kirin, Inc.
$29
Epizyme, Inc.,
$28
AbbVie Inc.
$28
MorphoSys, US Inc.
$28
GE HealthCare
$27
Jazz Pharmaceuticals Inc.
$27
Boston Scientific Corporation
$24
Acceleron Pharma, Inc.
$24
Dova Pharmaceuticals
$24
Fresenius Kabi USA, LLC
$23
G1 Therapeutics, Inc.
$21
CTI BioPharma Corp.
$20
Pharmacyclics LLC, an AbbVie Company
$19
Dendreon Pharmaceuticals LLC
$19
TerSera Therapeutics LLC
$18
Teva Pharmaceuticals USA, Inc.
$18
AVEO Pharmaceuticals, Inc.
$17
Epizyme, Inc.
$17
PUMA BIOTECHNOLOGY, INC.
$17
Acrotech Biopharma LLC
$17
EUSA Pharma (US) LLC
$16
TAIHO ONCOLOGY, INC.
$16
Sirtex Medical Inc
$16
Clovis Oncology, Inc.
$15
Ipsen Biopharmaceuticals, Inc
$15
PharmaEssentia USA Corporation
$15
TG Therapeutics, Inc.
$14
ImmunoGen, Inc.
$14
Shire North American Group Inc
$14
Fortovia Therapeutics, Inc.
$14
Innate Pharma, Inc
$14
ABBVIE INC.
$14
NOVARTIS PHARMACEUTICALS CORPORATION
$14
Alnylam Pharmaceuticals Inc.
$13
Lexicon Pharmaceuticals, Inc.
$13
Secura Bio, Inc.
$12
AMAG Pharmaceuticals, Inc.
$11
Prometheus Laboratories Inc.
$10
Aadi Bioscience, Inc.
$9
Top 3 companies account for 39.0% of all-time payments
Associated products mentioned in payments ›
ADAKVEO · ADCETRIS · AFINITOR · ALIMTA · ALUNBRIG · ASPARLAS · AUGTYRO · AYVAKIT · Alecensa · Aliqopa · Avastin · BELEODAQ · BENDEKA · BESREMI · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · Beleodaq · Blincyto · CABOMETYX · CALQUENCE · CEREZYME · CINVANTI · COSELA · CYRAMZA · Cabometyx · Columvi · Copiktra · DARZALEX · Doptelet · ELAHERE · ELIQUIS · ELITEK · ELREXFIO · EMEND · EMPLICITI · ENHERTU · ENJAYMO · ERLEADA · Elahere · Enhertu · Epkinly · Erleada · FERAHEME · FOTIVDA · FOUNDATIONONE · Farydak · Folotyn · Fyarro · GAUCHER-DISEASE · GAVRETO · GAZYVA · GILOTRIF · GIVLAARI · Halaven · Herceptin · IBRANCE · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · INQOVI · INREBIC · Imbruvica · JADENU · JAKAFI · JEMPERLI · JEVTANA · KANJINTI · KEYTRUDA · KISQALI · KRAZATI · Kadcyla · Kyprolis · LIBTAYO · LONSURF · LORBRENA · LUTATHERA · LYNPARZA · Lenvima · Lonsurf · Lumoxiti · Lunsumio · MEKINIST · MONJUVI · MONOFERRIC · MOVANTIK · Monoferric · NINLARO · Nerlynx · Neulasta · Nexavar · Nplate · Nubeqa · OGSIVEO · OJJAARA · ONUREG · OPDIVO · OPDUALAG · OXBRYTA · PADCEV · PEMAZYRE · PIQRAY · PROMACTA · PROSIGNA ASSAY · PROVENGE · PYRUKYND · Padcev · Perjeta · Pomalyst · Poteligeo · Proleukin · Prolia · QINLOCK · REBLOZYL · RETEVMO · ROLVEDON · RYBREVANT · Reblozyl · Revlimid · Rezlidhia · Rubraca · SANCUSO · SANDOSTATIN · SARCLISA · SCEMBLIX · SIR-Spheres Microspheres · SOLIRIS · SOMATULINE DEPOT · SPRYCEL · SUTENT · SpaceOAR VUE System - 10mL · Stimufend · Stivarga · Sylvant · TAFINLAR · TAGRISSO · TASIGNA · TAZVERIK · TECENTRIQ · TECVAYLI · TIBSOVO · TUKYSA · Tavalisse · Tazverik · Tecentriq · Tibsovo · Tivdak · Trodelvy · UKONIQ · ULTOMIRIS · VENCLEXTA · VERZENIO · VOTRIENT · VPRIV · VYXEOS · Vectibix · Venclexta · Vitrakvi · Vonjo · XALKORI · XARELTO · XPOVIO · XTANDI · Xermelo · Xofigo · Xtandi · Yescarta · ZEJULA · ZEPZELCA · Zoladex · clonoSEQ
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Hematology & oncology specialists in nearby ZIP areas
13
County median income
$88,046
Nearest hospital to ZIP centroid (approximate)
SHORE MEDICAL CENTER
4.5 mi
4.5 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Dave is a mixed practice specialist, with above-average Medicare volume (top 19% in NJ), with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Dave experienced with filgrastim injection, 1 microgram?
Based on Medicare claims data, Dr. Dave performed 16,860 filgrastim injection, 1 microgram services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Dave receive payments from pharmaceutical companies?
Yes. Dr. Dave received a total of $21,117 from 102 companies across 833 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Dave's costs compare to other hematology & oncology specialists in Marmora?
Dr. Dave's average Medicare payment per service is $14. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Dave) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Marmora
Browse hematology & oncology specialists in Marmora ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in NJ
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in NJ
Which NJ hematology & oncology specialists receive the most from drug and device companies.
By company
Kite Pharma, Inc. Payments to Doctors
See all physicians who received payments from Kite Pharma, Inc.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Blueprint Medicines Corporation Payments to Doctors
See all physicians who received payments from Blueprint Medicines Corporation.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology